San Francisco Chronicle - Sunday, July 27, 2003
Christopher Heredia, Chronicle Staff Writer
"This will give us the clearest picture yet of the magnitude of the U.S. HIV epidemic, the true incidence, telling us where it is occurring so we can improve the effectiveness of prevention programs," said Dr. Robert Janssen, director of HIV prevention at the Centers for Disease Control and Prevention.
In 1998, San Francisco health officials began using the blood test STARHS -- Serologic Testing Algorithm for Recent HIV Seroconversion -- that enables experts to pinpoint infections that occurred in the previous six months. Older HIV tests captured all infections, including those that occurred many years ago.
In the early years of the AIDS epidemic, the CDC and state health officials made estimates of where HIV was spreading based on the length of time between HIV infection and the onset of AIDS. With the advent of antiviral therapy, fewer people have developed full-blown AIDS, creating a significant gap in information about which groups are contracting HIV at the highest rates.
The CDC estimates that 40,000 people in the United States a year become infected with HIV.
"No one knows that for sure," said Dr. Tom Coates, director of the UCSF AIDS Research Institute. "San Francisco is the only place in the country that knows at any given time what percentage of the uninfected population is (contracting HIV) and how rapidly the infection is spreading."
Coates said the newer test results can also be helpful in determining a patient's treatment if the test is positive.
In San Francisco, the test has shown the highest rates of infection among gay and bisexual men, especially gay men of color, followed by the male-to- female transgender community.
"Using the test we've been able to determine those people who are at highest risk, and this is where we're spending most of our money in prevention, " said Mitch Katz, San Francisco's director of public health.
E-mail Christopher Heredia at cheredia@sfchronicle.com.
030727
SC030717
Copyright © 2003 - San Francisco Chronicle Press. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the San Francisco Chronicle, Permissions Desk, 901 Mission Street, San Franciso, CA 94103. You may also send a fax to (415) 495-3843, or an email message to chronperm@sfgate.com. http://www.sfgate.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .